Patent cliff fuels Novartis’ $1.5bn swoop for London biotech Healthcare Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiries over the next decade. The deal will see Novartis pay $1.1bn upfront, with a further $400m tied to development [...]
Should the wealthy always go private to save the NHS? healthcare It’s no secret that the NHS has been under pressure for years and the strain on its resources looks like not letting up any time soon. With staffing shortages, long waiting times, funding issues, an aging population and a rise in demand, the NHS has its back up against the wall. But should those who [...]
From deathbed to boardroom: Omaze CEO reveals how flatlining changed him forever Property Matt Pohlson “was supposed to die” when he was born and certainly not hang around long enough to found Omaze, the global juggernaut aiming to revolutionise the high-end property market. Born with a stomach twisted into a knot, Pohlson underwent surgery to save his life – an experience he thought was supposed to happen once [...]
Replace the NHS with Social Health Insurance says think tank September 19, 2024 The IEA has called for a radical transformation of the NHS, proposing it be replaced with a Social Health Insurance system to improve healthcare outcomes in the UK